{"entity":{"type":"insider","cik":"0001620564","url":"/insider/0001620564","json_url":"/insider/0001620564.json","name":"Salvadori Daniel Gesua Sive","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":24,"first":"2015-09-29","last":"2026-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Salvadori Daniel Gesua Sive","source":"filing","n_filings":24,"first_seen":"2015-09-29","last_seen":"2026-03-03"}],"transactions":[{"id":5863117,"accession":"0001620564-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001620564-26-000007","line_url":"/filing/0001620564-26-000007#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (EVP AND GROUP PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EVP AND GROUP PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GROUP PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":885.0,"shares_display":"885","price_per_share":115.58,"price_display":"115.58","price_state":"stated","total_value":102288.3,"total_display":"102,288.30","total_whole":"102,288","shares_owned_after":146377.0,"shares_owned_after_display":"146,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5079289,"accession":"0001415889-25-002584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-002584","line_url":"/filing/0001415889-25-002584#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23771.0,"shares_display":"23,771","price_per_share":128.5,"price_display":"128.50","price_state":"stated","total_value":3054573.5,"total_display":"3,054,573.50","total_whole":"3,054,574","shares_owned_after":125697.0,"shares_owned_after_display":"125,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-30","filed_date":"2025-01-31","scope":"insider"},{"id":2273581,"accession":"0001415889-24-006417","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-006417","line_url":"/filing/0001415889-24-006417#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":963.0,"shares_display":"963","price_per_share":118.5,"price_display":"118.50","price_state":"stated","total_value":114115.5,"total_display":"114,115.50","total_whole":"114,116","shares_owned_after":125697.0,"shares_owned_after_display":"125,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-04","scope":"insider"},{"id":7875182,"accession":"0001415889-23-003916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-003916","line_url":"/filing/0001415889-23-003916#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1085.0,"shares_display":"1,085","price_per_share":100.7,"price_display":"100.70","price_state":"stated","total_value":109259.5,"total_display":"109,259.50","total_whole":"109,260","shares_owned_after":119861.0,"shares_owned_after_display":"119,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":6617897,"accession":"0001415889-22-002200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-002200","line_url":"/filing/0001415889-22-002200#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1550.0,"shares_display":"1,550","price_per_share":118.171,"price_display":"118.17","price_state":"stated","total_value":183165.05,"total_display":"183,165.05","total_whole":"183,165","shares_owned_after":112248.0,"shares_owned_after_display":"112,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-02","scope":"insider"},{"id":5181356,"accession":"0001415889-21-006263","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-21-006263","line_url":"/filing/0001415889-21-006263#line-3","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58501.0,"shares_display":"58,501","price_per_share":140.0,"price_display":"140.00","price_state":"stated","total_value":8190140.0,"total_display":"8,190,140.00","total_whole":"8,190,140","shares_owned_after":100430.0,"shares_owned_after_display":"100,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-23","filed_date":"2021-12-28","scope":"insider"},{"id":4862699,"accession":"0001415889-21-005967","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-21-005967","line_url":"/filing/0001415889-21-005967","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58499.0,"shares_display":"58,499","price_per_share":135.0,"price_display":"135.00","price_state":"stated","total_value":7897365.0,"total_display":"7,897,365.00","total_whole":"7,897,365","shares_owned_after":103931.0,"shares_owned_after_display":"103,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider","n_lines":2},{"id":5483389,"accession":"0001415889-21-001212","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-21-001212","line_url":"/filing/0001415889-21-001212#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark":"O","role_mark_label":"Officer (EXECUTIVE VICE PRESIDENT)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EXECUTIVE VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1664.0,"shares_display":"1,664","price_per_share":120.61,"price_display":"120.61","price_state":"stated","total_value":200695.04,"total_display":"200,695.04","total_whole":"200,695","shares_owned_after":107430.0,"shares_owned_after_display":"107,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":2870472,"accession":"0001179110-20-009447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009447","line_url":"/filing/0001179110-20-009447#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42479.0,"shares_display":"42,479","price_per_share":111.86,"price_display":"111.86","price_state":"stated","total_value":4751700.94,"total_display":"4,751,700.94","total_whole":"4,751,701","shares_owned_after":102433.0,"shares_owned_after_display":"102,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-27","filed_date":"2020-08-31","scope":"insider"},{"id":2064221,"accession":"0001179110-20-002895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-002895","line_url":"/filing/0001179110-20-002895#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":999.0,"shares_display":"999","price_per_share":77.89,"price_display":"77.89","price_state":"stated","total_value":77812.11,"total_display":"77,812.11","total_whole":"77,812","shares_owned_after":103493.0,"shares_owned_after_display":"103,493","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-03","scope":"insider"},{"id":8553801,"accession":"0001179110-19-008174","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-19-008174","line_url":"/filing/0001179110-19-008174#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71000.0,"shares_display":"71,000","price_per_share":84.0001,"price_display":"84.00","price_state":"stated","total_value":5964007.1,"total_display":"5,964,007.10","total_whole":"5,964,007","shares_owned_after":96148.0,"shares_owned_after_display":"96,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-27","scope":"insider"},{"id":8449293,"accession":"0001179110-19-007613","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-19-007613","line_url":"/filing/0001179110-19-007613#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3331.0,"shares_display":"3,331","price_per_share":82.0,"price_display":"82.00","price_state":"stated","total_value":273142.0,"total_display":"273,142.00","total_whole":"273,142","shares_owned_after":96148.0,"shares_owned_after_display":"96,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-13","filed_date":"2019-06-13","scope":"insider"},{"id":8449290,"accession":"0001179110-19-007613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-007613","line_url":"/filing/0001179110-19-007613#line-1","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7269.0,"shares_display":"7,269","price_per_share":82.0,"price_display":"82.00","price_state":"stated","total_value":596058.0,"total_display":"596,058.00","total_whole":"596,058","shares_owned_after":99479.0,"shares_owned_after_display":"99,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-11","filed_date":"2019-06-13","scope":"insider"},{"id":7786451,"accession":"0001179110-19-003124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-19-003124","line_url":"/filing/0001179110-19-003124#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1664.0,"shares_display":"1,664","price_per_share":78.0,"price_display":"78.00","price_state":"stated","total_value":129792.0,"total_display":"129,792.00","total_whole":"129,792","shares_owned_after":106748.0,"shares_owned_after_display":"106,748","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider"},{"id":5958656,"accession":"0001179110-18-011958","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-011958","line_url":"/filing/0001179110-18-011958","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":73.3914,"price_display":"73.39","price_state":"stated","total_value":366957.0,"total_display":"366,957.00","total_whole":"366,957","shares_owned_after":88521.0,"shares_owned_after_display":"88,521","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-28","filed_date":"2018-10-02","scope":"insider","n_lines":2},{"id":6794741,"accession":"0001179110-18-007253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-007253","line_url":"/filing/0001179110-18-007253#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":61.5,"price_display":"61.50","price_state":"stated","total_value":61500.0,"total_display":"61,500.00","total_whole":"61,500","shares_owned_after":94581.0,"shares_owned_after_display":"94,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-21","scope":"insider"},{"id":6794737,"accession":"0001179110-18-007253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-18-007253","line_url":"/filing/0001179110-18-007253#line-1","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":61.046,"price_display":"61.05","price_state":"stated","total_value":122092.0,"total_display":"122,092.00","total_whole":"122,092","shares_owned_after":95581.0,"shares_owned_after_display":"95,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-21","scope":"insider"},{"id":6814340,"accession":"0001179110-18-003314","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-18-003314","line_url":"/filing/0001179110-18-003314#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":905.0,"shares_display":"905","price_per_share":58.971,"price_display":"58.97","price_state":"stated","total_value":53368.755,"total_display":"53,368.76","total_whole":"53,369","shares_owned_after":97581.0,"shares_owned_after_display":"97,581","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-02","scope":"insider"},{"id":5276209,"accession":"0001179110-17-015385","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-17-015385","line_url":"/filing/0001179110-17-015385","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28319.0,"shares_display":"28,319","price_per_share":54.91929513754017,"price_display":"54.92","price_state":"stated","total_value":1555259.519,"total_display":"1,555,259.52","total_whole":"1,555,260","shares_owned_after":92278.0,"shares_owned_after_display":"92,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-14","filed_date":"2017-12-14","scope":"insider","n_lines":8},{"id":5249582,"accession":"0001179110-17-014210","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-014210","line_url":"/filing/0001179110-17-014210#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71157.0,"shares_display":"71,157","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":3913635.0,"total_display":"3,913,635.00","total_whole":"3,913,635","shares_owned_after":73798.0,"shares_owned_after_display":"73,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-14","filed_date":"2017-11-16","scope":"insider"},{"id":4773510,"accession":"0001179110-17-013439","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-17-013439","line_url":"/filing/0001179110-17-013439#line-3","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96603.0,"shares_display":"96,603","price_per_share":56.21,"price_display":"56.21","price_state":"stated","total_value":5430054.63,"total_display":"5,430,054.63","total_whole":"5,430,055","shares_owned_after":73798.0,"shares_owned_after_display":"73,798","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-23","filed_date":"2017-10-25","scope":"insider"},{"id":5153621,"accession":"0001179110-17-012749","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-17-012749","line_url":"/filing/0001179110-17-012749#line-4","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62460.0,"shares_display":"62,460","price_per_share":52.95,"price_display":"52.95","price_state":"stated","total_value":3307257.0,"total_display":"3,307,257.00","total_whole":"3,307,257","shares_owned_after":79285.0,"shares_owned_after_display":"79,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-26","filed_date":"2017-09-28","scope":"insider"},{"id":4072395,"accession":"0001179110-17-003680","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-17-003680","line_url":"/filing/0001179110-17-003680#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2066.0,"shares_display":"2,066","price_per_share":45.39,"price_display":"45.39","price_state":"stated","total_value":93775.74,"total_display":"93,775.74","total_whole":"93,776","shares_owned_after":72112.0,"shares_owned_after_display":"72,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-01","filed_date":"2017-03-02","scope":"insider"},{"id":2499034,"accession":"0001179110-16-030075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-16-030075","line_url":"/filing/0001179110-16-030075#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":815.0,"shares_display":"815","price_per_share":41.711,"price_display":"41.71","price_state":"stated","total_value":33994.465,"total_display":"33,994.46","total_whole":"33,994","shares_owned_after":58976.0,"shares_owned_after_display":"58,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-26","filed_date":"2016-09-28","scope":"insider"},{"id":2651959,"accession":"0001179110-16-020732","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-16-020732","line_url":"/filing/0001179110-16-020732","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":881.0,"shares_display":"881","price_per_share":39.26154597048808,"price_display":"39.26","price_state":"stated","total_value":34589.422,"total_display":"34,589.42","total_whole":"34,589","shares_owned_after":61973.0,"shares_owned_after_display":"61,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-29","filed_date":"2016-03-02","scope":"insider","n_lines":3},{"id":8916502,"accession":"0001179110-15-013392","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-013392","line_url":"/filing/0001179110-15-013392","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001620564","owner_name":"Salvadori Daniel Gesua Sive","owner_display_name":"Salvadori Daniel Gesua Sive","owner_url":"/insider/0001620564","role":"Officer (Senior Vice President)","role_mark":"O","role_mark_label":"Officer (Senior Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":815.0,"shares_display":"815","price_per_share":39.64626380368098,"price_display":"39.65","price_state":"stated","total_value":32311.705,"total_display":"32,311.70","total_whole":"32,312","shares_owned_after":39974.0,"shares_owned_after_display":"39,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-28","filed_date":"2015-09-29","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000001800","name":"ABBOTT LABORATORIES","url":"/issuer/0000001800","role":"Officer (EVP AND GROUP PRESIDENT)","n_filings":24,"first_seen":"2015-09-29","last_seen":"2026-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001620564","retrieved_at":"2026-08-23T14:32:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}